The following defining attributes correspond to the Clinical Finding/Disorder Attributes Summary table. 

After

This attribute is used to model concepts in which a clinical finding occurs after another clinical finding, procedure or event. Neither asserting nor excluding a causal relationship, it instead emphasizes a sequence of events. This attribute is self-grouped.  

For example,

• •  occurs  

A clinical finding may start either:  after a variable period of time; immediately following the resolution of its antecedent; or during the course of its antecedent but continue after the antecedent has resolved. These sequences correspond to Allen's interval algebra relations of:

• X takes place before Y

• X meets Y 

• X overlaps with Y
  

Associated morphology

This attribute specifies the morphologic changes seen at the tissue or cellular level that are characteristic of a disease.

(Please see Morphologic Abnormalities vs. Findings for details).

For example,

• •  has an Associated morphology (attribute) of 

When selecting a value for this attribute, in general, the concept should not represent a body structure combined with the morphology. There are, however, exceptions, i.e. where a morphology implies the finding site:

For example,

• • Thymoma (morphologic abnormality)
  • External hyperostosis (morphologic abnormality)
  • Odontoma (morphologic abnormality)

Body structure should be captured in the value selected for the Finding site attribute. There are, however, exceptions. 

For example,

• •  has  of  and a  of 

Stated view of Lymphoid hyperplasia of appendix (disorder)

Associated with

 represents a clinically relevant association between concepts without either asserting or excluding a causal or sequential relationship between the two.  In general, avoid using the  as it may be ambiguous and difficult to apply consistently.  

This attribute is self-grouped. 

Areas of content that use this attribute:

• • Devices
  • Intolerance to substances
  • Concepts that group specific associations

For example,

Stated view of 6211002 |Polyarthritis associated with another disorder (disorder)| using the |Associated with (attribute)|

Before

This attribute is used to model pre-procedure complications (e.g, preoperative complication). It represents temporal associations between procedures and related disorders.  This attribute is self-grouped.  

Causative agent

This attribute identifies an organism, substance, physical object, physical force, and/or pharmaceutical/biological product as the direct cause of a condition. It does not include vectors, for example, a mosquito that transmits malaria.

For example, 

• •  has the  of 

Although Pharmaceutical / biologic product (product) and its descendants are considered valid values for Causative agent (attribute) by the MRCM, they are not currently used as values for this attribute in the International Release. The only exception is 787859002 |Vaccine product (medicinal product)| and its descendants, which can be used as valid values for this attribute.

The following guidelines should be considered where the causative agent is a substance:

Concepts representing a clinical finding caused by a base substance (e.g., 836284001 |Pentamethonium (substance)|), a substance structure grouper (e.g. 1149501006 |Substance with ether structure (substance)|), or a substance disposition grouper (e.g. 404642006 |Substance with opioid receptor agonist mechanism of action (substance)|) should be modeled using a causative agent that is a descendant of 105590001 |Substance (substance)|. Classification results are expected to be consistent with the modeling in the Substance hierarchy:

For example,

• 93419003 |Contact dermatitis caused by nickel (disorder)|

• 13503000 |Poisoning caused by naloxone (disorder)|

• 767116002 |Allergy to substance with ether structure (finding)|

• 870376001 |Adverse reaction to dopamine receptor agonist (disorder)|

Concepts representing a clinical finding caused by a substance role grouper (e.g., 372688009 |Antineoplastic agent (substance)|) currently follow the same guidelines noted above. However, role groupers will be transitioned from the Substance hierarchy to the 763158003 |Medicinal product (product)| hierarchy in a future release.

For example,

• 295597003 |Antineoplastic overdose (disorder)|

Concepts representing a clinical finding caused by a substance modification (e.g., 82485006 |Pentamethonium bromide (substance)|) are generally not allowed. Exceptions may be included if the condition caused by the substance modification is significantly different from the one caused by the base substance. Exceptions may include Liposome or lipid complex substances, Pegylated substances, or salt forms:

For example,

• 293908005 |Allergy to chloral hydrate (finding)|

• 296213007 |Fluphenazine decanoate overdose (disorder)|

Clinical course

This attribute is used to represent both the course and onset of a disease or condition.  This attribute is self-grouped.  

For example, 

• •  has a  of 

The clinical course value is added when appropriate to the condition and thus specified in the FSN.  The distinction is often necessary in those conditions that can have either an acute or a chronic course, such as bronchitis. For those conditions that have only one clinical course, i.e. diabetes is a chronic disease, a wider discussion is necessary before a decision can be made whether to assign a clinical course.  Decisions on these concepts are currently made on a case-by-case basis. 

Many conditions with acute (sudden) onsets also have acute (short-term) courses.  Few conditions with chronic (long-term) durations require rapid versus gradual onset subtyping. Thus, there is no clear need for separating the rapidity of onset from the duration of a disease.  The clinical course attribute, which combines onset and course, has been more reproducible and useful than two attributes that attempt to separate the meanings. 

Due to

This attribute is used to identify a clinical finding/disorder, event, or procedure concept as the direct cause of another Clinical finding or Disorder concept.  If the clinical finding merely predisposes to another disorder, rather than causing it directly, the more general  is used instead.  

This attribute is self-grouped.  

For example,

During

This attribute is used to model concepts in which a clinical finding occurs during a procedure. Neither asserting nor excluding a causal relationship, it instead emphasizes a sequence of events.  This attribute is self-grouped.  

For example, 

• •  has the value Surgical procedure (procedure) for During (attribute)

Episodicity

This attribute is used to represent episodes of care provided by a physician or other healthcare provider, not episodes of disease experienced by the patient.

For example,

• • Asthma with of  represents the first time the patient presents to their healthcare provider with asthma.

Finding informer

This attribute specifies the person or other entity from which the clinical finding information was obtained. It is not about the particular individual but about the category or type of informer. It is used to differentiate patient-reported symptoms from provider-determined signs. This attribute is frequently used in conjunction with . 

Finding method

This attribute specifies the means by which a clinical finding was determined. It includes findings that were determined by examination of the patient. Finding method is frequently used with Finding informer. 

For example,

• •  has the  of

Finding site

This attribute specifies the body site affected by a condition. 

For example, 

• •  has  of 

Has interpretation 

This attribute refers to and designates the judgment aspect being evaluated or interpreted (e.g. presence, absence, degree, normality, abnormality, etc.).  Subtypes of Environment or geographical location (environment / location) can also be used as the value in cases such as specifying a location of an incident to be reported to death and injury registries. 

Interprets and Has Interpretation are grouped together in a relationship group without any other attributes. 

For example,

Inferred view of Inadequate intake of vitamin D and vitamin D derivative (finding)

Qualifier values of |Below reference range| and |Above reference range| are preferred over values such as high/low, increased/decreased, etc. to describe Measurement finding (finding) concepts.

Interprets

This attribute refers to the entity being evaluated or interpreted, when an evaluation, interpretation, or judgment is intrinsic to the meaning of a concept. 

Interprets and Has Interpretation are grouped together in a relationship group without any other attributes.  Interprets may be used in a relationship group by itself without any other attributes if the value of the observable is not defined.

For example, 

Stated view of |Decreased muscle tone (finding)|

In general, the value for the |Interprets| attribute should be from the |Observable entity| hierarchy rather than the |Procedure| hierarchy. 

|Observable entity| concepts that are modeled with a |Scale type (attribute)| relationship should not be used as a value for a Clinical finding's |Interprets| relationship.  The existing vital sign |Observable entity| concepts, e.g. |Arterial blood pressure (observable entity)| are exceptions to this guideline; they are permitted for use.  

Be aware that SNOMED CT currently contains some concepts in the |Evaluation Procedure| hierarchy which logically belong in the |Observable entity| hierarchy. Reconciliation of the overlap between these two hierarchies will be undertaken at a future date. Discussions about the final solution for the |Observable entity| and |Evaluation Procedure| issue are ongoing. See Observable Entity vs. Evaluation procedure. 

When working with the Interprets attribute, consider the values used by the supertypes and possible subtypes of your concept for this attribute. This is because the |Interprets| values must be drawn from the same hierarchy, e.g. |Observable entity| hierarchy or |Procedure| hierarchy as supertypes and subtypes, to support modeling and correct subsumption.  

Has realization

This attribute is used to specify the process or activity that is the consequence of realization of the function. 

Occurrence

This attribute refers to the specific period of life during which a condition first presents. However, conditions may persist beyond the period of life when they first present.

For example, 

• •  has the  of 

Pathological process

This attribute provides information about the underlying pathological process of a disorder, i.e. it describes the process that results in the structural or morphologic change. 

and its subtype  are included in the range for . These are used in modeling the subhierarchy. 

For example,

• •  has the  of

must not be used for values that could overlap with  .

For example,

• • Inflammatory processes result in inflammation (by definition), but these disorders should be defined by their morphology, i.e. 

Disorders which involve congenital anomalies are defined with the following grouped attribute-value pairs:

• Occurrence (attribute) = congenital (qualifier value)
• Associated morphology (attribute) = << 49755003 |Morphologically abnormal structure (morphologic abnormality)|
• Pathological process (attribute) = pathological development process (qualifier value)
• Finding site = X (body structure)
  
  

Severity

This attribute is used to subclass a Clinical finding concept according to its severity. However, this use is relative, i.e. it is incorrect to assume that the disease intensity or hazard is the same for all clinical findings to which this attribute is applied. 

The severity attribute may be applied to subtypes of Clinical finding (excluding << Symptom severity (finding)) to represent the severity of a finding or disease.  

While this attribute is useful to create subtypes of specific concepts and to differentiate the severity of a single disorder, it is not commonly used, and care must be taken when applying it. This is because:

• Severity may be interpreted in different ways, depending on the set of values available. Consider the different meaning of severity in each of the following value sets:
  
  • mild / moderate / severe
  • minimal / mild / moderate / severe / very severe
  • mild / mild to moderate / moderate / moderate to severe / severe / life threatening / fatal
• Severity is defined relative to the expected degree of intensity or hazard of the Clinical finding that is being qualified. For example, the common cold has a baseline intensity or hazard that is much less than a more serious disease like lupus erythematosus or pneumonia; thus, a severe cold might be considered less intense or less hazardous than mild pneumonia.
• Some disorders that are life-threatening do not ordinarily have a severity assigned to them. Cancer, for example, is not usually described as mild, moderate, or severe, but rather by stage or grade.

The Severity attribute is not applied to subtypes of 162465004 |Symptom severity (finding)| because the severity of a symptom is different to the severity of a disease.  Please note this piece of guidance does not align with the MRCM but is an editorial guideline. 

Temporally related to

726633004 |Temporally related to (attribute)| applies to perioperative complications and clinical findings where there is no causal relationship, but a time-relative association exists.

The attribute subhierarchy specifies the associated time period (i.e. before, during, after) between two procedures, two clinical findings, or a procedure and a clinical finding, e.g. perioperative complications temporally related to a surgical procedure (i.e. preoperative, intraoperative, and postoperative); Multisystem inflammatory syndrome in children temporally associated with SARS-CoV-2.  This attribute is self-grouped.